| 12/05 | FENNEC PHARMACEUTICALS INC. Management's Discussion and Analysis of Financial Conditio.. | AQ |
| 12/05 | Fennec Pharmaceuticals Announces First Quarter 2022 Financial Results and Provides Busi.. | GL |
| 28/04 | Fennec pharmaceuticals announces fda acceptance for filing of new drug application resu.. | AQ |
| 27/04 | Fennec Pharmaceuticals Announces FDA Acceptance for Filing of New Drug Application Resu.. | GL |
| 05/04 | FENC ALERT : The Klein Law Firm Announces a Lead Plaintiff Deadline of April 11, 2022 in t.. | PR |
| 29/03 | FENC ALERT : The Klein Law Firm Announces a Lead Plaintiff Deadline of April 11, 2022 in t.. | PR |
| 28/03 | Fennec pharmaceuticals to participate in the 2022 maxim virtual growth conference | AQ |
| 25/03 | Fennec Pharmaceuticals to Participate in the 2022 Maxim Virtual Growth Conference | GL |
| 24/03 | FENNEC PHARMACEUTICALS : RESUBMITS NEW DRUG APPLICATION TO U.S. FOOD AND DRUG ADMINSTRATIO.. | PU |
| 24/03 | FENNEC PHARMACEUTICALS INC. : Other Events, Financial Statements and Exhibits (form 8-K) | AQ |
| 24/03 | Fennec Pharmaceuticals Resubmits New Drug Application to U.S. Food and Drug Administrat.. | AQ |
| 22/03 | FENC ALERT : The Klein Law Firm Announces a Lead Plaintiff Deadline of April 11, 2022 in t.. | PR |
| 15/03 | FENC ALERT : The Klein Law Firm Announces a Lead Plaintiff Deadline of April 11, 2022 in t.. | PR |
| 08/03 | FENC ALERT : The Klein Law Firm Announces a Lead Plaintiff Deadline of April 11, 2022 in t.. | PR |
| 01/03 | FENC ALERT : The Klein Law Firm Announces a Lead Plaintiff Deadline of April 11, 2022 in t.. | PR |
| 28/02 | FENNEC PHARMACEUTICALS INC. Management's Discussion and Analysis of Financial Conditio.. | AQ |
| 28/02 | Fennec Pharmaceuticals Announces Fiscal Year 2021 Financial Results And Provides Busine.. | GL |
| 15/02 | FENC ALERT : The Klein Law Firm Announces a Lead Plaintiff Deadline of April 11, 2022 in t.. | PR |
| 14/02 | SHAREHOLDER ALERT : Robbins LLP Reminds Investors That Fennec Pharmaceuticals Inc. (FENC) .. | BU |
| 11/02 | Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigati.. | BU |
| 11/02 | INVESTOR ALERT : Law Offices of Howard G. Smith Announces Investigation of Fennec Pharmace.. | BU |
| 11/02 | SHAREHOLDER ALERT : Robbins LLP Informs Investors that Fennec Pharmaceuticals Inc. (FENC) .. | BU |
| 11/02 | The Law Offices of Frank R. Cruz Announces Investigation of Fennec Pharmaceuticals Inc... | BU |
| 10/02 | Bronstein, Gewirtz & Grossman, LLC Notifies Fennec Pharmaceuticals Inc. (FENC) Investor.. | BU |
| 10/02 | Bronstein, Gewirtz & Grossman, LLC Notifies Fennec Pharmaceuticals Inc. (FENC) Investor.. | BU |
| 31/01 | FENNEC PHARMACEUTICALS : ANNOUNCES MANAGEMENT CHANGE - Form 8-K | PU |
| 31/01 | FENNEC PHARMACEUTICALS INC. : Entry into a Material Definitive Agreement, Financial Statem.. | AQ |
| 31/01 | FENNEC PHARMACEUTICALS INC. : Change in Directors or Principal Officers, Financial Stateme.. | AQ |
| 31/01 | Fennec Pharmaceuticals Announces Management Change | AQ |
| 17/01 | FENNEC PHARMACEUTICALS : Corporate Presentation January 2022 | PU |
| 2021 | SHAREHOLDER ALERT : Pomerantz Law Firm Investigates Claims On Behalf of Investors of Fenne.. | PR |
| 2021 | FENNEC PHARMACEUTICALS : Receives Complete Response Letter from the FDA for its New Drug A.. | PU |
| 2021 | Fennec Pharmaceuticals Receives Complete Response Letter from the FDA for its New Drug .. | AQ |
| 2021 | Fennec pharmaceuticals expects to receive complete response letter from the fda for its.. | AQ |
| 2021 | FENNEC PHARMACEUTICALS : Expects to Receive Complete Response Letter from the FDA for its .. | PU |
| 2021 | FENNEC PHARMACEUTICALS INC. : Other Events, Financial Statements and Exhibits (form 8-K) | AQ |
| 2021 | Fennec Pharmaceuticals Expects to Receive Complete Response Letter from the FDA for its.. | GL |
| 2021 | FENNEC PHARMACEUTICALS INC. Management's Discussion and Analysis of Financial Conditio.. | AQ |
| 2021 | Fennec Pharmaceuticals Announces Third Quarter 2021 Financial Results and Provides Busi.. | GL |
| 2021 | Fennec Pharmaceuticals Announces Third Quarter 2021 Financial Results and Provides Busi.. | GL |
| 2021 | FENNEC PHARMACEUTICALS : to Participate in Upcoming Investor Conferences | AQ |
| 2021 | FENNEC PHARMACEUTICALS : Management's Discussion and Analysis of Financial Condition and R.. | AQ |
| 2021 | Fennec Pharmaceuticals Announces Second Quarter 2021 Financial Results and Provides Bus.. | GL |
| 2021 | FENNEC PHARMACEUTICALS INC. : Submission of Matters to a Vote of Security Holders (form 8-.. | AQ |
| 2021 | Fennec Announces Results of Annual Meeting | GL |
| 2021 | FENNEC PHARMACEUTICALS : ANNOUNCES AMENDMENT TO INCREASE EXISTING SENIOR DEBT FACILITY (Fo.. | PU |
| 2021 | FENNEC PHARMACEUTICALS INC. : Entry into a Material Definitive Agreement, Other Events, Fi.. | AQ |
| 2021 | Fennec Pharmaceuticals Announces Amendment to Increase Existing Senior Debt Facility | GL |
| 2021 | FENNEC PHARMACEUTICALS : Announces FDA Acceptance of New Drug Application Resubmission for.. | AQ |
| 2021 | FENNEC PHARMACEUTICALS : ANNOUNCES FDA ACCEPTANCE OF NEW DRUG APPLICATION RESUBMISSION FOR.. | PU |
| 2021 | FENNEC PHARMACEUTICALS INC. : Other Events, Financial Statements and Exhibits (form 8-K) | AQ |
| 2021 | FENNEC PHARMACEUTICALS : Announces fda acceptance of new drug application resubmission for.. | PU |
| 2021 | Fennec Pharmaceuticals Announces FDA Acceptance of New Drug Application Resubmission fo.. | GL |
| 2021 | FENNEC PHARMACEUTICALS : Resubmits new drug application to u.s. food and drug administrati.. | AQ |
| 2021 | FENNEC PHARMACEUTICALS : Resubmits New Drug Application to U.S. Food and Drug Administrati.. | AQ |
| 2021 | Fennec Pharmaceuticals Announces First Quarter 2021 Financial Results and Provides Busi.. | GL |
| 2021 | FENNEC PHARMACEUTICALS : Management's Discussion and Analysis of Financial Condition and R.. | AQ |
| 2020 | Fennec Pharmaceuticals Announces Third Quarter 2020 Financial Results and Provides Busi.. | GL |
| 2020 | Fennec Announces Issuance of U.S. Patent for PEDMARK™ | GL |
| 2020 | Law Offices of Howard G. Smith Continues Investigation of Fennec Pharmaceuticals Inc. (.. | BU |
| 2020 | THE LAW OFFICES OF FRANK R. CRUZ : Continues Its Investigation of Fennec Pharmaceuticals I.. | BU |
| 2020 | GLANCY PRONGAY & MURRAY LLP : a Leading Securities Fraud Law Firm, Continues Investigation.. | BU |
| 2020 | Kirby McInerney LLP Continues Investigation of Shareholder Claims Against Fennec Pharma.. | BU |
| 2020 | FENNEC ALERT : Bragar Eagel & Squire, P.C. is Investigating Fennec Pharmaceuticals, Inc. o.. | BU |
| 2020 | INVESTIGATION REMINDER : The Schall Law Firm Announces it is Investigating Claims Against .. | BU |
| 2020 | GLANCY PRONGAY & MURRAY LLP : a Leading Securities Fraud Law Firm, Announces Investigation.. | BU |
| 2020 | THE LAW OFFICES OF FRANK R. CRUZ : Announces Investigation of Fennec Pharmaceuticals Inc. .. | BU |
| 2020 | Law Offices of Howard G. Smith Announces Investigation of Fennec Pharmaceuticals Inc. (.. | BU |
| 2020 | INVESTIGATION ALERT : The Schall Law Firm Announces it is Investigating Claims Against Fen.. | BU |
| 2020 | Fennec Pharmaceuticals to Participate in Upcoming Investor Conferences | GL |
| 2020 | Fennec Pharmaceuticals Announces Second Quarter 2020 Financial Results and Provides Bus.. | GL |
| 2020 | Fennec Pharmaceuticals Announces Amendment to Increase Existing Senior Debt Facility | GL |
| 2020 | Fennec Pharmaceuticals Announces First Quarter 2020 Financial Results and Provides Busi.. | GL |
| 2020 | Fennec Announces Exercise and Closing of Underwriters' Option to Purchase Additional Sh.. | GL |
| 2020 | Fennec Announces Closing of Public Offering | GL |
English (USA)
English (UK)
English (Canada)
Deutsch (Deutschland)
Deutsch (Schweiz)
Español
Français (France)
Italiano
Nederlands (België)
Rapport
